Zobrazeno 1 - 10
of 187
pro vyhledávání: '"Toshiyuki Kunisada"'
Autor:
Eiji Nakata, Tomohiro Fujiwara, Toshiyuki Kunisada, Ryuichi Nakahara, Haruyoshi Katayama, Takuto Itano, Toshifumi Ozaki
Publikováno v:
Journal of Orthopaedic Surgery and Research, Vol 18, Iss 1, Pp 1-7 (2023)
Abstract Purpose Soft tissue sarcomas (STS) of the forearm are rare. We aim to assess their oncological and functional outcomes. Methods We retrospectively evaluated 34 patients who underwent surgical excision for forearm STS at our institution betwe
Externí odkaz:
https://doaj.org/article/831c14fba640494baced6d65584a7f51
Autor:
Toshiyuki Kunisada, Eiji Nakata, Tomohiro Fujiwara, Toshiaki Hata, Kohei Sato, Haruyoshi Katayama, Ayana Kondo, Toshifumi Ozaki
Publikováno v:
Biomimetics, Vol 9, Iss 5, p 294 (2024)
Unidirectional porous hydroxyapatite (UDPHAp) was developed as a remarkable scaffold characterized by a distinct structure with unidirectional pores oriented in the horizontal direction and connected through interposes. We evaluated the radiographic
Externí odkaz:
https://doaj.org/article/1d209613ae3b410bb4d09b8d791a72c9
Autor:
Koji Uotani, Hiroshi Tazawa, Joe Hasei, Tomohiro Fujiwara, Aki Yoshida, Yasuaki Yamakawa, Toshinori Omori, Kazuhisa Sugiu, Tadashi Komatsubara, Hiroya Kondo, Takuya Morita, Masahiro Kiyono, Suguru Yokoo, Toshiaki Hata, Toshiyuki Kunisada, Ken Takeda, Yasuo Urata, Toshiyoshi Fujiwara, Toshifumi Ozaki
Publikováno v:
PLoS ONE, Vol 19, Iss 2, p e0298292 (2024)
Bone and soft-tissue sarcomas are rare malignancies with histological diversity and tumor heterogeneity, leading to the lack of a common molecular target. Telomerase is a key enzyme for keeping the telomere length and human telomerase reverse transcr
Externí odkaz:
https://doaj.org/article/58fc91a9ec63459b8c0966eb8e2ea242
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Alveolar soft part sarcoma (ASPS) is a rare histological subtype of soft-tissue sarcoma, which remains refractory to conventional cytotoxic chemotherapy. We aimed to characterize ASPS and investigate whether the oncological outcom
Externí odkaz:
https://doaj.org/article/f5546e94787b4467ae97be3bc0fd7371
Autor:
Yoshinao Oda, Kazuhiro Tanaka, Takanori Hirose, Tadashi Hasegawa, Nobuyuki Hiruta, Masanori Hisaoka, Masato Yoshimoto, Hiroshi Otsuka, Hirofumi Bekki, Takeaki Ishii, Makoto Endo, Toshiyuki Kunisada, Toru Hiruma, Hiroyuki Tsuchiya, Hirohisa Katagiri, Yoshihiro Matsumoto, Akira Kawai, Robert Nakayama, Hiroyuki Kawashima, Satoshi Takenaka, Makoto Emori, Munenori Watanuki, Yukihiro Yoshida, Takeshi Okamoto, Junki Mizusawa, Haruhiko Fukuda, Toshifumi Ozaki, Yukihide Iwamoto, Takayuki Nojima
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Preoperative chemotherapy is widely applied to high-grade localized soft tissue sarcomas (STSs); however, the prognostic significance of histological response to chemotherapy remains controversial. This study aimed to standardize
Externí odkaz:
https://doaj.org/article/f883ac7597a54050a846995537069a8b
Autor:
Toshiyuki Kunisada, Joe Hasei, Tomohiro Fujiwara, Eiji Nakata, Suguru Yokoo, Koji Demiya, Toshifumi Ozaki
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-8 (2020)
Abstract Unidirectional porous hydroxyapatite (UDPHAp) was developed as an excellent scaffold with unidirectional pores oriented in the horizontal direction with interpore connections. The purpose of this study was to assess radiographic changes and
Externí odkaz:
https://doaj.org/article/77ec8dfa9d704794a55513300e26c8b0
Autor:
Makoto Endo, Shunji Takahashi, Nobuhito Araki, Hideshi Sugiura, Takafumi Ueda, Tsukasa Yonemoto, Mitsuru Takahashi, Hideo Morioka, Hiroaki Hiraga, Toru Hiruma, Toshiyuki Kunisada, Akihiko Matsumine, Kazato Goda, Akira Kawai
Publikováno v:
Cancer Medicine, Vol 9, Iss 11, Pp 3656-3667 (2020)
Abstract The time course of the response to each drug is important to avoid inappropriate termination of treatment by misjudging tumor progression; however, little is known about soft tissue sarcoma (STS) regarding this matter. This study aimed to pe
Externí odkaz:
https://doaj.org/article/72f22d66938e4509814e74c406f73671
Autor:
Akihiko Takeuchi, Akihiro Nomura, Norio Yamamoto, Katsuhiro Hayashi, Kentaro Igarashi, Susumu Tandai, Akira Kawai, Akihiko Matsumine, Shinji Miwa, Yoshihiro Nishida, Tomoki Nakamura, Ryu Terauchi, Manabu Hoshi, Toshiyuki Kunisada, Makoto Endo, Kenichi Yoshimura, Toshinori Murayama, Hiroyuki Tsuchiya
Publikováno v:
BMC Musculoskeletal Disorders, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background A tenosynovial giant cell tumor (TGCT) is a locally aggressive benign neoplasm arising from intra- or extra-articular tissue. Diffuse TGCT (D-TGCT) most commonly develops in the knee, followed by the hip, ankle, elbow, and shoulde
Externí odkaz:
https://doaj.org/article/c53a67ebfdb8407798f2da4ae60745fc
Autor:
Hiroshi Urakawa, Tsukasa Yonemoto, Seiichi Matsumoto, Tatsuya Takagi, Kunihiro Asanuma, Munenori Watanuki, Akira Takemoto, Norifumi Naka, Yoshihiro Matsumoto, Akira Kawai, Toshiyuki Kunisada, Tadahiko Kubo, Makoto Emori, Hiroaki Hiraga, Hiroshi Hatano, Satoshi Tsukushi, Yoshihiro Nishida, Toshihiro Akisue, Takeshi Morii, Mitsuru Takahashi, Akihito Nagano, Hideki Yoshikawa, Kenji Sato, Masanori Kawano, Koji Hiraoka, Kazuhiro Tanaka, Yukihide Iwamoto, Toshifumi Ozaki
Publikováno v:
World Journal of Surgical Oncology, Vol 16, Iss 1, Pp 1-8 (2018)
Abstract Background Giant cell tumor of bone (GCTB) is an intermediate tumor known to be locally aggressive, but rarely metastasizing. To plan a prospective study of GCTB, we performed a questionnaire survey for institutions participating in the Bone
Externí odkaz:
https://doaj.org/article/06fc3859d18c4c1fbaf9c9d009b5284c
Autor:
Ryoji Joko, Daisuke Yamada, Masahiro Nakamura, Aki Yoshida, Shota Takihira, Tomoka Takao, Ming Lu, Kohei Sato, Tatsuo Ito, Toshiyuki Kunisada, Eiji Nakata, Toshifumi Ozaki, Takeshi Takarada
Publikováno v:
Translational Oncology, Vol 14, Iss 1, Pp 100960- (2021)
Paired related homeobox 1 (PRRX1) is a marker of limb bud mesenchymal cells, and deficiency of p53 or Rb in Prrx1-positive cells induces osteosarcoma in several mouse models. However, the regulatory roles of PRRX1 in human osteosarcoma have not been
Externí odkaz:
https://doaj.org/article/1971cd31bce84d06be2c73ad535dfdeb